Thus, minimizing the effective dose is extremely significant.[ 59 , 60 , 61 ] On the other hand, the calcineurin-independent immunosuppressive agent sirolimus, a binder of mTOR, inhibits tumor growth in cell lines; it inhibits primary and metastatic tumor growth in vivo .
1
—
—